Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers

A. J. Cronin, N. M. Aucutt-Walter, T. Budinetz, C. P. Bonafide, N. A. DiVittore, V. Gordin, H. G. Schuler, R. H. Bonneau

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background. Mu opioid agonists suppress natural killer (NK) cell activity in animal models. Studies in human volunteers, however, have yielded conflicting results, with morphine suppressing and fentanyl increasing NK cell activity. This study evaluated the effect of a constant 8-h infusion of remifentanil on NK cell number and function in human volunteers. Methods. After IRB approval and informed consent was obtained, 10 healthy volunteers underwent an 11 pm to 7 am infusion of saline, and at least 1 week later an infusion of 0.02-0.04 μg kg-1 min-1 remifentanil. Blood was collected at 7 am for measurement of NK cell cytotoxicity using a 51Cr release assay and measurement of NK cell number using fluorescent flow cytometry. Results. Median and range of the total NK cell cytoxicity (KU ml-1) was 745.0 (498.3-1483.6) on the control morning and 818.6 (238.5-1454.5) on the morning following the remifentanil infusion. Neither the number of NK cells ml-1 (2.5×105 (1.4×105-4.2×105) vs 2.7×1O5 (1.1×105- 4.4×105)) nor the cytotoxicity per 1000 NK cells (KU 1000 NK cells-1) (3.0 (1.8-5.2) vs 2.9 (0.9-6.7)) changed between the control and remifentanil conditions. Conclusions. An 8-h infusion of remifentanil did not affect NK cell activity in normal volunteers. This result differs from previous findings of morphine-induced NK cell activity suppression and fentanyl-induced NK cell activity enhancement in normal volunteers.

Original languageEnglish (US)
Pages (from-to)805-809
Number of pages5
JournalBritish Journal of Anaesthesia
Volume91
Issue number6
DOIs
StatePublished - Dec 2003

Fingerprint

Natural Killer Cells
Healthy Volunteers
Fentanyl
Morphine
remifentanil
Volunteers
Cell Count
Research Ethics Committees
Informed Consent
Opioid Analgesics
Flow Cytometry
Animal Models

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Cronin, A. J. ; Aucutt-Walter, N. M. ; Budinetz, T. ; Bonafide, C. P. ; DiVittore, N. A. ; Gordin, V. ; Schuler, H. G. ; Bonneau, R. H. / Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. In: British Journal of Anaesthesia. 2003 ; Vol. 91, No. 6. pp. 805-809.
@article{c88312fe5f81499398d719da1b80dfcb,
title = "Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers",
abstract = "Background. Mu opioid agonists suppress natural killer (NK) cell activity in animal models. Studies in human volunteers, however, have yielded conflicting results, with morphine suppressing and fentanyl increasing NK cell activity. This study evaluated the effect of a constant 8-h infusion of remifentanil on NK cell number and function in human volunteers. Methods. After IRB approval and informed consent was obtained, 10 healthy volunteers underwent an 11 pm to 7 am infusion of saline, and at least 1 week later an infusion of 0.02-0.04 μg kg-1 min-1 remifentanil. Blood was collected at 7 am for measurement of NK cell cytotoxicity using a 51Cr release assay and measurement of NK cell number using fluorescent flow cytometry. Results. Median and range of the total NK cell cytoxicity (KU ml-1) was 745.0 (498.3-1483.6) on the control morning and 818.6 (238.5-1454.5) on the morning following the remifentanil infusion. Neither the number of NK cells ml-1 (2.5×105 (1.4×105-4.2×105) vs 2.7×1O5 (1.1×105- 4.4×105)) nor the cytotoxicity per 1000 NK cells (KU 1000 NK cells-1) (3.0 (1.8-5.2) vs 2.9 (0.9-6.7)) changed between the control and remifentanil conditions. Conclusions. An 8-h infusion of remifentanil did not affect NK cell activity in normal volunteers. This result differs from previous findings of morphine-induced NK cell activity suppression and fentanyl-induced NK cell activity enhancement in normal volunteers.",
author = "Cronin, {A. J.} and Aucutt-Walter, {N. M.} and T. Budinetz and Bonafide, {C. P.} and DiVittore, {N. A.} and V. Gordin and Schuler, {H. G.} and Bonneau, {R. H.}",
year = "2003",
month = "12",
doi = "10.1093/bja/aeg273",
language = "English (US)",
volume = "91",
pages = "805--809",
journal = "British Journal of Anaesthesia",
issn = "0007-0912",
publisher = "Oxford University Press",
number = "6",

}

Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. / Cronin, A. J.; Aucutt-Walter, N. M.; Budinetz, T.; Bonafide, C. P.; DiVittore, N. A.; Gordin, V.; Schuler, H. G.; Bonneau, R. H.

In: British Journal of Anaesthesia, Vol. 91, No. 6, 12.2003, p. 805-809.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers

AU - Cronin, A. J.

AU - Aucutt-Walter, N. M.

AU - Budinetz, T.

AU - Bonafide, C. P.

AU - DiVittore, N. A.

AU - Gordin, V.

AU - Schuler, H. G.

AU - Bonneau, R. H.

PY - 2003/12

Y1 - 2003/12

N2 - Background. Mu opioid agonists suppress natural killer (NK) cell activity in animal models. Studies in human volunteers, however, have yielded conflicting results, with morphine suppressing and fentanyl increasing NK cell activity. This study evaluated the effect of a constant 8-h infusion of remifentanil on NK cell number and function in human volunteers. Methods. After IRB approval and informed consent was obtained, 10 healthy volunteers underwent an 11 pm to 7 am infusion of saline, and at least 1 week later an infusion of 0.02-0.04 μg kg-1 min-1 remifentanil. Blood was collected at 7 am for measurement of NK cell cytotoxicity using a 51Cr release assay and measurement of NK cell number using fluorescent flow cytometry. Results. Median and range of the total NK cell cytoxicity (KU ml-1) was 745.0 (498.3-1483.6) on the control morning and 818.6 (238.5-1454.5) on the morning following the remifentanil infusion. Neither the number of NK cells ml-1 (2.5×105 (1.4×105-4.2×105) vs 2.7×1O5 (1.1×105- 4.4×105)) nor the cytotoxicity per 1000 NK cells (KU 1000 NK cells-1) (3.0 (1.8-5.2) vs 2.9 (0.9-6.7)) changed between the control and remifentanil conditions. Conclusions. An 8-h infusion of remifentanil did not affect NK cell activity in normal volunteers. This result differs from previous findings of morphine-induced NK cell activity suppression and fentanyl-induced NK cell activity enhancement in normal volunteers.

AB - Background. Mu opioid agonists suppress natural killer (NK) cell activity in animal models. Studies in human volunteers, however, have yielded conflicting results, with morphine suppressing and fentanyl increasing NK cell activity. This study evaluated the effect of a constant 8-h infusion of remifentanil on NK cell number and function in human volunteers. Methods. After IRB approval and informed consent was obtained, 10 healthy volunteers underwent an 11 pm to 7 am infusion of saline, and at least 1 week later an infusion of 0.02-0.04 μg kg-1 min-1 remifentanil. Blood was collected at 7 am for measurement of NK cell cytotoxicity using a 51Cr release assay and measurement of NK cell number using fluorescent flow cytometry. Results. Median and range of the total NK cell cytoxicity (KU ml-1) was 745.0 (498.3-1483.6) on the control morning and 818.6 (238.5-1454.5) on the morning following the remifentanil infusion. Neither the number of NK cells ml-1 (2.5×105 (1.4×105-4.2×105) vs 2.7×1O5 (1.1×105- 4.4×105)) nor the cytotoxicity per 1000 NK cells (KU 1000 NK cells-1) (3.0 (1.8-5.2) vs 2.9 (0.9-6.7)) changed between the control and remifentanil conditions. Conclusions. An 8-h infusion of remifentanil did not affect NK cell activity in normal volunteers. This result differs from previous findings of morphine-induced NK cell activity suppression and fentanyl-induced NK cell activity enhancement in normal volunteers.

UR - http://www.scopus.com/inward/record.url?scp=0345099557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345099557&partnerID=8YFLogxK

U2 - 10.1093/bja/aeg273

DO - 10.1093/bja/aeg273

M3 - Article

C2 - 14633749

AN - SCOPUS:0345099557

VL - 91

SP - 805

EP - 809

JO - British Journal of Anaesthesia

JF - British Journal of Anaesthesia

SN - 0007-0912

IS - 6

ER -